Literature DB >> 148301

Study of a kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) and compensated hemolysis.

S F Travis, J Martinez, J Garvin, J Atwater, P Gillmer.   

Abstract

A kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) was studied. The propositus presented with indirect hyperbilirubinemia, normal hemoglobin (15.8 g/dl), and elevated reticulocyte count (4.6%). The red cell 51Cr survival was decreased (tau1/2 16 days). Incubated osmotic fragility was normal; autohemolysis was increased and corrected with glucose and ATP. The P50 was 18.5 mm Hg (normal 25.5 +/- 3), but the stability, electrophoresis, and fingerprinting of hemoglobin were normal. The concentration of 2,3-diphosphoglycerate (2,3-DPG) was reduced to 43% of normal. Red cell 2,3-DPGM was decreased to 59% of normal; 2,3-DPG phosphatase was similarly decreased. All red cell glycolytic and hexose monophosphate shunt enzymes, glycolytic intermediates other than 2,3-DPG, and glucose consumption and lactate production were normal. Five family members showed similar hematologic findings. The deficiency appears to be secondary to decreased enzyme synthesis and to be inherited as an autosomal dominant trait in this family. Partial deficiency of 2,3-DPGM should now be considered in the differential diagnosis of compensated hemolysis associated with increased oxygen affinity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 148301

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  An enzyme-linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes.

Authors:  T Takubo; I Tsuda; N Tatsumi; K Kasuya; Y Taniguchi; T Fujita; K Uchida; Y Matsuo; T Hayashi
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

3.  Erythrocytosis associated with a novel missense mutation in the BPGM gene.

Authors:  Nayia Petousi; Richard R Copley; Terence R J Lappin; Sally E Haggan; Celeste M Bento; Holger Cario; Melanie J Percy; Peter J Ratcliffe; Peter A Robbins; Mary Frances McMullin
Journal:  Haematologica       Date:  2014-07-11       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.